These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6052853)

  • 1. Effect of diazoxide on plasma renin activity in hypertensive patients.
    Küchel O; Fishman LM; Liddle GW; Michelakis A
    Ann Intern Med; 1967 Oct; 67(4):791-9. PubMed ID: 6052853
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of diazoxide on blood pressure, PRA and plasma aldosterone in hypertensive patients (author's transl)].
    Mantero F; Perini A; Armanini D; Gion M; Opocher G; Boscaro M
    G Ital Cardiol; 1976; 6(7):1246-53. PubMed ID: 1010235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renin-angiotensin-aldosterone system: effect of the hypertensive agents on plasma renin activity and clinical application, especially in screening of primary aldosteronism and other simialr diseases].
    Suzuki T
    Jpn Circ J; 1970 Mar; 34(3):187-97. PubMed ID: 5468432
    [No Abstract]   [Full Text] [Related]  

  • 4. Diazoxide and renal function in man.
    Johnson BF
    Clin Pharmacol Ther; 1971; 12(5):815-24. PubMed ID: 4936146
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma renin activity and aldosterone secretion in hypertensive patients during high and low sodium intake and administration of diuretic.
    Weinberger MH; Dowdy AJ; Nokes GW; Luetscher JA
    J Clin Endocrinol Metab; 1968 Mar; 28(3):359-71. PubMed ID: 5642688
    [No Abstract]   [Full Text] [Related]  

  • 6. Aldosterone studies in obese patients with hypertension.
    Marks P; Wilson B; Delassalle A
    Am J Med Sci; 1985 Jun; 289(6):224-8. PubMed ID: 3890539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a new beta-adrenergic blocker, l-bunolol, on blood pressure and on the renin-aldosterone system.
    Gavras H; Gavras I; Brunner HR; Laragh JH
    J Clin Pharmacol; 1977; 17(5-6):350-7. PubMed ID: 323300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole decreases circulating renin-angiotensin system activity in hypertensive patients.
    Taddei S; Arzilli F; Arrighi P; Salvetti A
    Am J Hypertens; 1992 Jan; 5(1):29-31. PubMed ID: 1736931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary salt intake in hypertensive patients with normal and low plasma renin activity.
    Adlin EV; Biddle CM; Channick BJ
    Am J Med Sci; 1971 Feb; 261(2):67-71. PubMed ID: 5550136
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic studies on hypertensive patients with suppressed plasma renin activity not due to hyperaldosternosm.
    Helmer OM; Judson WE
    Circulation; 1968 Nov; 38(5):965-76. PubMed ID: 5697693
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of beta1-receptor blockade (Metoprolol, Selokenr) on blood pressure, pulse rate, plasma catecholamines, renin activity and urinary aldosterone.
    Hansson BG; Hökfelt B
    Acta Med Scand Suppl; 1976; 602():94-6. PubMed ID: 800317
    [No Abstract]   [Full Text] [Related]  

  • 12. The natriuresis of fasting: relationship to changes in plasma renin and plasma aldosterone concentrations.
    Chinn RH; Brown JJ; Fraser R; Heron SM; Lever AF; Murchison L; Robertson JI
    Clin Sci; 1970 Sep; 39(3):437-55. PubMed ID: 5459169
    [No Abstract]   [Full Text] [Related]  

  • 13. The antihypertensive action of methyldopa in relation to its effect on the renin-aldosterone system.
    Gavras H; Gavras I; Brunner HR; Laragh JH
    J Clin Pharmacol; 1977 Jul; 17(7):372-8. PubMed ID: 881470
    [No Abstract]   [Full Text] [Related]  

  • 14. [SP 54 therapy in hypertension. The effect of SP 54 on blood pressure, renin and aldosterone as well as electrolyte balance in patients with hypertension].
    Werning C; Stiel D; Hammann K; Schweikert HU; Fischer N; Siegenthaler W
    Fortschr Med; 1972 Jul; 90(20):785-7. PubMed ID: 5074231
    [No Abstract]   [Full Text] [Related]  

  • 15. Clonidine in primary hypertension: effects on blood pressure, plasma renin activity, plasma and urinary aldosterone.
    Karlberg BE; Nilsson O; Tolagen K
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):10-20. PubMed ID: 401703
    [No Abstract]   [Full Text] [Related]  

  • 16. Differing effects of the vasodilator drugs, prazosin and diazoxide on plasma renin activity in the dog.
    Graham RM; Muir MR; Hayes JM
    Clin Exp Pharmacol Physiol; 1976; 3(2):173-7. PubMed ID: 975613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium space and electrolyte excretion during the menstrual cycle.
    Michelakis AM; Stant EG; Brill AB
    Am J Obstet Gynecol; 1971 Jan; 109(1):150-4. PubMed ID: 5538963
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenously administered chlorothiazide in diagnostic evaluation of hypertensive disease.
    McGuffin WL; Gunnells JC
    Arch Intern Med; 1969 Feb; 123(2):124-30. PubMed ID: 5763614
    [No Abstract]   [Full Text] [Related]  

  • 19. Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.
    Bühler FR; Laragh JH; Baer L; Vaughan ED; Brunner HR
    N Engl J Med; 1972 Dec; 287(24):1209-14. PubMed ID: 5084985
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of indapamide on the renin-aldosterone system, and urinary excretion of potassium and calcium in essential hypertension.
    Danielsen H; Pedersen EB; Spencer ES
    Br J Clin Pharmacol; 1984 Aug; 18(2):229-31. PubMed ID: 6386023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.